
Results
167
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
167 companies
Bonraybio
Market Cap: NT$2.8b
A development stage company, manufactures medical instruments and solutions for the male infertility market.
6955
NT$114.00
7D
-5.4%
1Y
-30.3%
Bayer (Peru)
Market Cap: S/294.5m
Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.
BAYERI1
S/20.00
7D
0%
1Y
41.8%
Jeil Pharma Holdings
Market Cap: ₩97.9b
Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.
A002620
₩6,380.00
7D
-2.7%
1Y
-31.3%
Pangaea Oncology
Market Cap: €56.4m
A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.57
7D
4.0%
1Y
-5.4%
hVIVO
Market Cap: UK£47.1m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.069
7D
-3.5%
1Y
-31.5%
Immuno-Biological Laboratories
Market Cap: JP¥9.3b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥994.00
7D
-0.4%
1Y
100.0%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$30.25
7D
-1.6%
1Y
0.8%
Synbio Tech
Market Cap: NT$1.8b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$51.30
7D
4.1%
1Y
-59.6%
Avecho Biotechnology
Market Cap: AU$78.5m
A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India.
AVE
AU$0.021
7D
-10.9%
1Y
310.0%
CCME Global
Market Cap: ₹5.2b
Does not have significant operations.
514336
₹114.95
7D
-3.2%
1Y
391.4%
Haleos Labs
Market Cap: ₹4.8b
Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
HALEOSLABS
₹1,587.30
7D
-2.0%
1Y
38.1%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$378.9m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.34
7D
25.9%
1Y
11.5%
BIO-FD&CLtd
Market Cap: ₩70.1b
Develops active ingredients for anti-aging cosmetics in South Korea.
A251120
₩8,060.00
7D
-5.8%
1Y
-58.2%
WDB coco
Market Cap: JP¥6.2b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,563.00
7D
-0.3%
1Y
-12.6%
Winston Medical Supply
Market Cap: NT$1.1b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$60.20
7D
0%
1Y
-46.3%
Prince Pharmaceutical
Market Cap: NT$1.1b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$30.25
7D
0%
1Y
14.2%
P&K Skin Research Center
Market Cap: ₩49.6b
Engages in the evaluation and research of dermatological products in South Korea.
A347740
₩1,718.00
7D
-3.1%
1Y
-45.1%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
-24.8%
Pharma-Bio Serv
Market Cap: US$12.9m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.56
7D
0%
1Y
-5.8%
Par Drugs and Chemicals
Market Cap: ₹1.1b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹91.68
7D
1.3%
1Y
-3.2%
Vineet Laboratories
Market Cap: ₹649.0m
Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India.
VINEETLAB
₹33.79
7D
-0.09%
1Y
5.7%
Phong Phu Pharmaceutical
Market Cap: ₫158.4b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
PPP
₫18,000.00
7D
0%
1Y
-11.8%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%